Cargando…

Preclinical evaluation and pilot clinical study of [(18)F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts

In recent years, fibroblast activation protein (FAP) has emerged as an attractive target for the diagnosis and radiotherapy of cancers using FAP-specific radioligands. Herein, we aimed to design a novel (18)F-labeled FAP tracer ([(18)F]AlF-P-FAPI) for FAP imaging and evaluated its potential for clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Kongzhen, Li, Junqi, Wang, Lijuan, Huang, Yong, Li, Li, Ye, Shimin, Han, Yanjiang, Huang, Shun, Wu, Hubing, Su, Jin, Tang, Ganghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897030/ https://www.ncbi.nlm.nih.gov/pubmed/35256951 http://dx.doi.org/10.1016/j.apsb.2021.09.032

Ejemplares similares

Automatic Production and Preliminary PET Imaging of a New Imaging Agent [(18)F]AlF-FAPT
por: Huang, JiaWen, et al.
Publicado: (2022)

Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [(18)F]AlF-NOTA-FAPI-04 PET/CT Imaging
por: Sun, Fangfang, et al.
Publicado: (2023)

FAPI-04 PET/CT Using [(18)F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient
por: Jiang, Xiao, et al.
Publicado: (2021)

Biological Evaluation of [(18)F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma
por: Lin, Liping, et al.
Publicado: (2021)

Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide (18)F-iCREKA: Comparison with Its Contrasted Linear Peptide
por: Zhang, Yin, et al.
Publicado: (2019)

[(18)F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer
por: Wei, Yuchun, et al.
Publicado: (2021)

[(18)F] AlF‑NOTA‑FAPI‑04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with (18)F-FDG
por: Yang, Liping, et al.
Publicado: (2023)

Synthesis and Evaluation of (18)F-Labeled Peptide for Gonadotropin-Releasing Hormone Receptor Imaging
por: Huang, Shun, et al.
Publicado: (2019)

Radiosynthesis and Biological Evaluation of N-[(18)F]Labeled Glutamic Acid as a Tumor Metabolic Imaging Tracer
por: Hu, Kongzhen, et al.
Publicado: (2014)

FAPI-74 PET/CT Using Either (18)F-AlF or Cold-Kit (68)Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
por: Giesel, Frederik L., et al.
Publicado: (2021)

Development of a Novel PET Tracer [(18)F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging
por: Liu, Qinghua, et al.
Publicado: (2015)

Utility of [(68)Ga]FAPI-04 and [(18)F]FDG dual-tracer PET/CT in the initial evaluation of gastric cancer
por: Miao, Ying, et al.
Publicado: (2022)

Activated fibroblasts in muscle sarcoidosis revealed by [(18)F]FAPI-74 PET
por: Watabe, Tadashi, et al.
Publicado: (2023)

Comparison of three (18)F-labeled carboxylic acids with (18)F-FDG of the differentiation tumor from inflammation in model mice
por: Wang, Hongliang, et al.
Publicado: (2016)

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD
por: Zang, Jie, et al.
Publicado: (2022)

A proper protocol for routine (18)F-FDG uEXPLORER total-body PET/CT scans
por: Hu, Huiran, et al.
Publicado: (2023)

One-pot and one-step automated radio-synthesis of [(18)F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment
por: Naka, Sadahiro, et al.
Publicado: (2021)

Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [(18)F]F-FDG PET/CT in Patients with Liver Malignancies
por: Siripongsatian, Dheeratama, et al.
Publicado: (2022)

Preclinical comparative study of [(18)F]AlF-PSMA-11 and [(18)F]PSMA-1007 in varying PSMA expressing tumors
por: Piron, Sarah, et al.
Publicado: (2022)

Preparation, Optimisation, and In Vitro Evaluation of [(18)F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET
por: Hassan, Hishar, et al.
Publicado: (2022)

Optimal clinical protocols for total-body 18F-FDG PET/CT examination under different activity administration plans
por: Huang, Yanchao, et al.
Publicado: (2023)

(18)F-labeled tracers targeting fibroblast activation protein
por: Lindner, Thomas, et al.
Publicado: (2021)

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
por: Gilardi, Laura, et al.
Publicado: (2022)

Molecular PET Imaging of Cyclophosphamide Induced Apoptosis with (18)F-ML-8
por: Yao, Shaobo, et al.
Publicado: (2015)

[(18)F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[(18)F]FDG PET/CT
por: Mu, Xingyu, et al.
Publicado: (2022)

(68)Ga- or (18)F-FAPI PET/CT—what it can and cannot
por: Mori, Yuriko, et al.
Publicado: (2023)

[(18)F]AlF-NOTA-ADH-1: A new PET molecular radiotracer for imaging of N-cadherin-positive tumors
por: Liu, Zhenfeng, et al.
Publicado: (2023)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma
por: Zhang, Jing, et al.
Publicado: (2023)

Evaluation of (18)F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with (68)Ga-DOTATATE PET/CT
por: Hou, Jiale, et al.
Publicado: (2021)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Evaluation of [(18)F]AlF-EMP-105 for Molecular Imaging of C-Met
por: Teh, Jin Hui, et al.
Publicado: (2023)

Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT
por: Lin, Xinfeng, et al.
Publicado: (2023)

Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of (68)Ga-Labeled FAPI Dimer
por: Zhao, Liang, et al.
Publicado: (2022)

A new F-18 labeled PET tracer for fatty acid imaging
por: Demeure, Fabian, et al.
Publicado: (2014)

Comparison of (18)F-FDG PET/CT and (68)Ga-FAPI in Spindle Cell Rhabdomyosarcoma
por: Shen, Zhihui, et al.
Publicado: (2023)

FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
por: Huang, Rong, et al.
Publicado: (2022)

Radiosynthesis and preliminary biological evaluation of N-(2-[(18)F]fluoropropionyl)-L-glutamine as a PET tracer for tumor imaging
por: Tang, Caihua, et al.
Publicado: (2016)

Semi-automatic synthesis and biodistribution of N-(2-(18)F-fluoropropionyl)-bis(zinc (II)-dipicolylamine) ((18)F-FP-DPAZn2) for AD model imaging
por: Wen, Fuhua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4qdj4qinnnp3r94b40gmdvtpc7